Second shot boosts protection for moderate-severe Covid-19 to 94 percent: JnJ Ruchika Sharma22 Sept 2021 10:00 AM ISTNew Delhi: Johnson & Johnson said Tuesday a second shot of its COVID-19 vaccine given about two months after the first increased its effectiveness...
Johnson and Johnson two-dose vaccine against Ebola safe, claims study MD Bureau16 Sept 2021 10:30 AM ISTLondon: The two-dose vaccine against Ebola virus developed by US drug maker Johnson and Johnson is safe, well tolerated and produces a strong immune...
Moderna COVID vaccine superior to Pfizer, JnJ against Delta, claims study MD Bureau11 Sept 2021 9:30 AM ISTNew York: Moderna's vaccine for Covid-19 is significantly more effective against the Delta variant of the SARS-CoV2 virus than Pfizer or Johnson &...
Covid-19: Aspen Pharmacare eyes Serum Institute model as it seeks licence to make JnJ vaccine Ruchika Sharma4 Sept 2021 9:00 AM ISTJohannesburg: South Africa's Aspen Pharmacare wants to model itself on India's Serum Institute by getting a licence to manufacture Johnson &...
JnJ HIV vaccine fails Imbokodo trial Ruchika Sharma1 Sept 2021 4:54 PM ISTThe Imbokodo study showed a 25.2% vaccine efficacy, based on which, the drugmaker said the study will not continue.
Second dose provides strong boost against Covid-19: JnJ MD Bureau27 Aug 2021 9:00 AM ISTWashington: The second dose of Johnson & Johnson's Covid-19 vaccine generates a strong immune response against the deadly virus among people...
JnJ eyes CDSCO nod for single shot COVID vaccine trials in 12-17 year olds MD Bureau20 Aug 2021 11:40 AM ISTNew Delhi: The American-based pharma major Johnson & Johnson (J&J) has applied to the Central Drugs Standard Control Organisation (CDSCO)...
JnJ gets DCGI emergency use approval for single dose COVID vaccine Ruchika Sharma7 Aug 2021 4:51 PM ISTNew Delhi: Johnson & Johnson's single-dose COVID-19 vaccine has been given Emergency Use approval in India, Union Health minister Mansukh...
Still in talks with Indian govt on COVID vaccine: Johnson and Johnson Ruchika Sharma2 Aug 2021 5:56 PM ISTBengaluru: Johnson & Johnson said on Monday it was still in talks with the Indian government over its COVID-19 vaccine after the country's...
JnJ single-shot COVID vaccine shelf life extended by USFDA to 6 months Ruchika Sharma29 July 2021 2:22 PM ISTNew Delhi: The U.S. Food & Drug Administration extended the shelf life for Johnson & Johnson's single-shot COVID-19 vaccine to six months...
Despite neurological illness reports, JnJ Covid-19 vaccine benefits outweigh risks: US CDC advisers Ruchika Sharma23 July 2021 12:45 PM ISTNew Delhi: Despite reports of a rare neurological disorder appearing in some people who have received Johnson & Johnson's COVID-19 vaccine, the...
Strong quarter from Johnson and Johnson as some operations return to normal Ruchika Sharma22 July 2021 9:30 AM ISTNew Delhi: Johnson & Johnson's second-quarter profit soared 73%, thanks to strong sales growth across all of its businesses, particularly its...
